CanBiocin Inc. is a privately held R&D company that specializes on development of innovative and socially beneficial lactic acid bacteria-based products. CanBiocin was formed in 1998 as a University of Alberta spin-off company to commercialize novel technologies developed from research conducted by professors Michael Stiles, Lynn McMullen and John Vederas. CanBiocin is also able to conduct a range of testing services for companies.